Open AccessEvaluation of CD30/CD4/CD8 in triple-negative invasive ductal carcinoma of breast in association with clinicopathological prognostic factors
Author(s) -
Amir Hossein Jafarian,
Aida Tasbandi,
Hamed Gilan,
Maryam Sheikhi,
Nema Mohamadian Roshan
Publication year - 2018
Publication title -
indian journal of pathology and microbiology/indian journal of pathology and microbiology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.217
H-Index - 31
eISSN - 0974-5130
pISSN - 0377-4929
DOI - 10.4103/ijpm.ijpm_67_18
Subject(s) - invasive ductal carcinoma , medicine , oncology , triple negative breast cancer , ductal carcinoma , triple negative , association (psychology) , pathology , breast cancer , cancer , psychology , psychotherapist
Triple-negative breast cancer (TNBC) lacks the benefits of receptor-targeted therapeutic strategies. The limitations in treatment options along with poor patients' outcome heighten the need for novel approaches. Due to recent concentration on the role of biomarkers in prognosis, treatment, and survival of various cancer subtypes, this study involves an investigation of CD4, CD8, and CD30 markers detected by immunohistochemistry in TNBCs and their association with clinicopathological and prognostic factors.